Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001086788 | SCV000285422 | benign | Tuberous sclerosis 2 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568541 | SCV000675606 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000841450 | SCV000983417 | likely benign | not provided | 2020-10-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28643795) |
Genome- |
RCV001086788 | SCV002039530 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000568541 | SCV002533980 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-10 | criteria provided, single submitter | curation | |
Ce |
RCV000841450 | SCV004129873 | likely benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | TSC2: BP4 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000841450 | SCV004221463 | uncertain significance | not provided | 2014-11-17 | criteria provided, single submitter | clinical testing |